Skip to content

Clinical trials

Insulin Resistance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Clear all

2,957 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
200112
200233
200350
200466
200598
2006124
2007115
2008136
2009159
2010118
2011156
2012143
2013133
2014143
2015122
2016129
2017115
2018137
2019131
202086
2021100
2022109
2023117
2024119
2025119
2026113

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2,012
Unknown status345
Recruiting216
Terminated133
Withdrawn83
Active, not recruiting79
Not yet recruiting63
Enrolling by invitation15
Suspended11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Aarhus45
Maastricht University Medical Center44
Massachusetts General Hospital44
University of Copenhagen37
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)35
Pennington Biomedical Research Center35
Stanford University33
University of Alabama at Birmingham27
Mayo Clinic25
University of Colorado, Denver24

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance2,957
Obesity680
Diabetes Mellitus, Type 2587
Diabetes Mellitus475
Metabolic Syndrome320
Diabetes Mellitus, Type 1179
Inflammation173
Overweight167
Glucose Intolerance157
Prediabetic State144

Trials

Showing 1 to 25 of 2,957. Each trial links to its page on Pharma Observatory.

2,857 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.